Skip to content
Research Article Open access CC BY 3.0

Erythropoietic and Bone Marrow Stimulating Activity of Terminalia catappa Extract: Possible Role of Nitric Oxide Signaling

I. A. Aimola, H. M. Inuwa, A. J. Nok, A. I. Mamman, N. Habila, A. Muhammad, A. S. Agbaji, A. Igoche, K. Ogungbemi, M. Tighil, Y. Usman

International Blood Research & Reviews · pp. 1–13 · Published 12 Dec 2012

10.9734/IBRR/2013/1812

Abstract

Aims: We assessed the capacity and mechanism of Terminalia catappa (TC) to induce erythropoiesis in vivo in phenylhydrazine- induced anemic mice. Place and Duration of Study: Sample: This study was carried out at Department of Biochemistry and Center for Biotechnology Research and Training Ahmadu Bello University Zaria, and National Research Institute for Chemical Technology, Zaria. The duration spanned between Jan 2011 and Feb 2012. Methodology: Solvent fractions of Terminalia catappa aqueous extract was used to treat phynylhydrazine-induced anemic mice. Treatment was done for four days, erythropoietic activity of each fraction was assayed by determining the effect of these fractions on intracellular hemoglobin and reticulocyte level from the blood, arginase was also assayed. Bone marrow carbonic anhydrase was assayed to monitor bone marrow erythropoietic stimulation. Results: Terminalia catappa was able to up-regulate the synthesis of intracellular hemoglobin (0.135 ±0.004 μmol/0.1ml) significantly comparable to hydroxyurea (HU) (0.158±0.006 μmol/0.1ml), and normalize the peripheral blood reticulocyte index significantly at P<.05 0.94±0.25% close to the non anemic mice 0.97±0.25% and bone marrow carbonic anhydrase activity. TC inhibited arginase activity significantly (P<.05) comparable to hydroxyurea. Conclusion: The results demonstrate Terminalia catappa extract as an erythropoietic agent that supports normal erythroid differentiation in vivo in phenylhydrazine- induced anemic mice in a synergistic fashion.  

Terminalia catappa nitric oxide arginase phenylhydrazine sickle cell anemia erythropoiesis hemolytic anemia

References (34)

  1. 1 Plant sesquiterpenes induce hyphal branching in arbuscular mycorrhizal fungi [DOI]
  2. 2 Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes [DOI]
  3. 3 A common precursor for primitive erythropoiesis and definitive haematopoiesis [DOI]
  4. 4 ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTION [DOI]
  5. 5 High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men [DOI]
  6. 6 Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 [DOI]
  7. 7 Arginine Therapy [DOI]
  8. 8 The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis [DOI]
  9. 9 Arginase modulates nitric oxide production in activated macrophages [DOI]
  10. 10 Hydroxyurea induces fetal hemoglobin by the nitric oxide–dependent activation of soluble guanylyl cyclase [DOI]
  11. 11 Epigallocatechin Gallate, a Green Tea Polyphenol, Mediates NO-dependent Vasodilation Using Signaling Pathways in Vascular Endothelium Requiring Reactive Oxygen Species and Fyn [DOI]
  12. 12 Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin [DOI]
  13. 13 The antimicrobial activities of methanolic extracts of Eucalyptus camaldulensis and Terminalia catappa against some pathogenic microorganisms [DOI]
  14. 14 Effect of Age and Diet on Insulin Secretion and Insulin Action in the Rat [DOI]
  15. 15 Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells [DOI]
  16. 16 Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels [DOI]
  17. 17 Hemozoin (Malarial Pigment) Directly Promotes Apoptosis of Erythroid Precursors [DOI]
  18. 18 In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells [DOI]
  19. 19 Hematologic, biochemical, and cardiopulmonary effects of l ‐arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy [DOI]
  20. 20 Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate [DOI]
  21. 21 Inhibition of arginase in rat and rabbit alveolar macrophages by Nω‐hydroxy‐ D , L ‐indospicine, effects on L ‐arginine utilization by nitric oxide synthase [DOI]
  22. 22 Clinical evaluation of cimetidine, sucralfate, and misoprostol for prevention of gastrointestinal tract bleeding in dogs undergoing spinal surgery [DOI]
  23. 23 Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina [DOI]
  24. 24 Expression, Purification and Characterization of Arginase from Helicobacter pylori in Its Apo Form [DOI]
  25. 25 Expression of the human carbonic anhydrase I gene is activated late in fetal erythroid development and regulated by stage‐specific trans‐acting factors [DOI]
  26. 26 ANTISICKLING ACTIVITY OF TERMINALIA CATAPPA LEAVES HARVESTED AT DIFFERENT STAGES OF GROWTH [DOI]
  27. 27 Bcl-XL is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its antiapoptotic function [DOI]
  28. 28 Physicochemical Analysis of the Aqueous Extracts of Six Nigerian Medicinal Plants [DOI]
  29. 29 Human erythroid progenitors from adult bone marrow and cord blood in optimized liquid culture systems respectively maintained adult and neonatal characteristics of globin gene expression [DOI]
  30. 30 Assay of carbonic anhydrase by titration at constant pH [DOI]
  31. 31 A role for nitric oxide in hydroxyurea-mediated fetal hemoglobin induction [DOI]
  32. 32 Terminalia catappa Extract Enhances Erythropoiesis in Adult Balb C Mice [DOI]
  33. 33 Switching globin, raising red cells [DOI]
  34. 34 Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin [DOI]

Cited by 4

Article metrics

Real usage data collected on this platform.

39

Page views

0

PDF downloads

5

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.